Team uses antibodies to tag disease-related proteins for destruction
Researchers have developed a technique utilising antibodies to tag disease-causing proteins, to treat the underlying causes of disease.
List view / Grid view
Researchers have developed a technique utilising antibodies to tag disease-causing proteins, to treat the underlying causes of disease.
Researchers have developed a CAR T-cell engineering technique to ensure that only cancer cells are targeted, leaving healthy cells alone in solid tumours.
Using cryo-electron microscopy, researchers have imaged how the SARS-CoV-2 Spike protein changes with the D614G mutation to enable faster spread of infection.
Researchers have developed a cell-based assay for the discovery of new IDO1 inhibitors, overcoming challenges from cell-free assays.
A large number of nanorobots in the bladders of mice have been visualised to reveal their movement and behaviour.
Scientists have created the first model of early human embryos by reprogramming fibroblasts into a blastocyst-like structures.
A novel machine learning method can explain how glycans stabilise proteins, aiding the discovery and design of protein-based drugs.
Researchers have shown that the PLpro coronavirus enzyme presents a possible target in the fight against COVID-19.
A novel machine learning method called DeepBAR could accelerate drug discovery and protein engineering, researchers say.
SARS-CoV-2 diverts building blocks from glucose production to the assembly of purine bases, researchers have found.
A team has developed nanolitre cell assays on droplet microarrays to enable pharmacodynamic monitoring in live cells.
An artificial intelligence platform has been created to enable tens of thousands of microscopy images to be generated in an hour.
Using X-ray crystallography and simulations, researchers have shown that APT2 is a hybrid between a lipid carrier protein and a hydrolase.
Thyroid mini-organs have been generated in the lab by researchers, which are able to self-renew and differentiate into functional tissue.
A team has revealed a function of ADAR1, responsible for RNA editing, discovering an isoform used for cancer growth, making it a drug target.